RYVER provide software to generate synthetic medical images and assess their privacy as well as quality.
Ryver has raised $1.4M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2023.
Ryver's investors include EWOR, Bayern Kapital, Nina Capital, Fund F.
Ryver is headquartered in München, Germany.
RYVER provide software to generate synthetic medical images and assess their privacy as well as quality.
Ryver is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ryver — Funding & Investors." VCBacked, December 6, 2023, https://www.vcbacked.co/company/ryver. Accessed October 9, 2026.
VCBacked. (2023). Ryver — Funding & Investors. Retrieved October 9, 2026, from https://www.vcbacked.co/company/ryver
{{cite web |title=Ryver — Funding & Investors |url=https://www.vcbacked.co/company/ryver |website=VCBacked |access-date=October 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated